Transfusion therapy with allogeneic blood components in children of cardiosurgical units

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article discusses features of allogeneic blood component transfusion in newborns and infants. This work is primarily addressed to specialists of "non–transfusiological" profile, such as neonatologists, anesthesiologists, intensive care specialists, pediatricians, hematologists and pediatric surgeons. Specific anatomical and physiological structure of child's organism, especially at its neonatologic period, specifies different approaches to the clinical application of donor blood components. However, description of transfusion therapy in children is found only in a small proportion of clinical recommendations, and its legislative level is regulated with an order of the Ministry of Health and the Government decree. Last documents are of administrative nature, and do not help much clinicians in specific decision-making situation. At the same time, transfusion with allogeneic blood is associated with significant complications. The overall prevalence of posttransfusion reactions in children is higher than in adults, and is associated with higher mortality rates. This is especially true for pediatric cardiac surgery. Application of donated blood after cardiopulmonary bypass surgery is associated with postoperative complications such as thrombosis, stroke, acute kidney injury, prolonged mechanical ventilation and death. The authors emphasize the necessity of scientific substantiation of each transfusion with evidence-based medicine. Indications for hemotransfusion have to rely not only on the concentration of hemoglobin and hematocrit, but also on additional physiological triggers. In order to minimize undesirable transfusion reactions and complications, modern technologies should be used to improve the quality of blood components. Attention is focused on modern components of donated blood. The review is aimed to summarize and structure current data on transfusion therapy in pediatric patients. The authors analyse domestic and foreign clinical recommendations and publications. Restrictive and liberal strategies of transfusion therapy are compared. Specific criteria for indications, algorithms for prescription, speed and volume of donor blood component infusion in pediatric units were revealed.

Full Text

Restricted Access

About the authors

Vadim S. Zyuzin

Federal High Medical Technologies Center

Author for correspondence.
Email: vadim.konignew@mail.ru
ORCID iD: 0009-0005-4868-8400

MD

Россия, Box p/o 5371, 236035 Kaliningrad

References

  1. Goobie SM, Gallagher T, Gross I, Shander A. Society for the advancement of blood management administrative and clinical standards for patient blood management programs. 4th edition (pediatric version). Paediatric Anaesth. 2019;29(3):231–236. doi: 10.1111/pan.13574
  2. Moncharmont P. Adverse transfusion reactions in transfused children. Transfus Clin Biol. 2019;26(4):329–335. doi: 10.1016/j.tracli.2019.08.002
  3. Wang Y, Sun W, Wang X, et al. Comparison of transfusion reactions in children and adults: A systematic review and meta-analysis. Pediatr Blood Cancer. 2022;69(9):e29842. EDN: JSDTTK doi: 10.1002/pbc.29842
  4. Kamyszek RW, Leraas HJ, Reed C, et al. Massive transfusion in the pediatric population: A systematic review and summary of best-evidence practice strategies. J Trauma Acute Care Surg. 2019;86(4):744–754. doi: 10.1097/TA.0000000000002188
  5. Busack C, Rana MS, Beidas Y, et al. Intraoperative blood product transfusion in pediatric cardiac surgery patients: A retrospective review of adverse outcomes. Paediatr Anaesth. 2023;33(5):387–397. doi: 10.1111/pan.14637
  6. Martinez MJ, Schwingshackl A, Romero T, et al. Cell saver blood transfusions may be associated with a decrease in inflammation and improved outcome measures in pediatric cardiac surgery patients. Perfusion. 2023;38(4):717–724. EDN: KOPZUV doi: 10.1177/02676591221078420
  7. Guerra GA, Ryerson L, Garros D, et al. Standard versus restrictive transfusion strategy for pediatric cardiac ECLS patients: Single center retrospective cohort study. ASAIO J. 2023;69(7):681–686. doi: 10.1097/MAT.0000000000001917
  8. Ivkin AA, Grigoriev E, Sinitskaya AV. Refraining from packed red blood cells in cardiopulmonary bypass priming as a method of neuroprotection in pediatric cardiac surgery. J Clin Med. 2023;12(4):1465. EDN: YXUKFZ doi: 10.3390/jcm12041465
  9. Faraoni D, Meier J, New HV, et al. Patient blood management for neonates and children undergoing cardiac surgery: 2019 NATA Guidelines. J Cardiothorac Vasc Anesth. 2019;33(12):3249–3263. EDN: HIJVNG doi: 10.1053/j.jvca.2019.03.036
  10. New HV, Stanworth SJ, Gottstein R, et al.; BSH Guidelines Transfusion Task Force. British society for haematology guidelines on transfusion for fetuses, neonates and older children (Br J Haematol. 2016;175:784–828). Br J Haematol. 2020;191(5):725–727. doi: 10.1111/bjh.17109
  11. Al-Mozain N, Arora S, Goel R, et al. Patient blood management in adults and children: What have we achieved, and what still needs to be addressed? Transfus Clin Biol. 2023;30(3):355–359. doi: 10.1016/j.tracli.2023.03.005
  12. Anaemia in malignant neoplasms. Clinical recommendations of the Ministry of Health of the Russian Federation. National Society of Haematology, National Society of Paediatric Haematologists, Oncology; 2017. (In Russ). Available from: https://oncology-association.ru/wp-content/uploads/2022/04/anemiya-pri-zlokachestvennyh-novoobrazovaniyah.pdf?ysclid=lumfqkpf8y725718047. Accessed: 15.01.2024.
  13. Tumours of the brain and spinal cord in children. Clinical recommendations of the Ministry of Health of the Russian Federation. Russian Society of Paediatric Oncologists (RSPO); 2017. (In Russ). Available from: https://neirodoc.ru/wp-content/uploads/2019/10/opuholi-golovnogo-i-spinnogo-mozga-u-detey-2017.pdf?ysclid=lumftjqawq41526173. Accessed: 15.01.2024.
  14. Nasopharyngeal Cancer in Children. Clinical recommendations of the Ministry of Health of the Russian Federation. Russian Society of Children's Oncologists, National Society of Children's Haematologists, Oncologists; 2020. (In Russ). Available from: https://xn--80axcg.xn--p1ai/wp-content/uploads/2022/09/Рак-носоглотки.pdf?ysclid=lumfwi183t982870119. Accessed: 15.01.2024.
  15. Franz AR, Engel C, Bassler D, et al. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: The ETTNO Randomized Clinical Trial. JAMA. 2022;328(2):217. doi: 10.1001/jama.2020.10690
  16. Kirpalani H, Bell EF, Hintz SR, et al. Higher or lower hemoglobin transfusion thresholds for preterm infants. N Engl J Med. 2020;324(6):560–570. doi: 10.1001/jama.2020.10690
  17. Holzapfel LF, Rysavy MA, Bell EF. Red blood cell transfusion thresholds for anemia of prematurity. Neoreviews. 2023;24(6):370–376. doi: 10.1542/neo.24-6-e370
  18. Duan ZX, Chen DX, Yang BZ, Zhang XQ. Transfusion strategies for pediatric cardiac surgery: A meta-analysis and trial sequential analysis. Pediatr Cardiol. 2021;42(6):1241–1251. doi: 10.1007/s00246-021-02644-8
  19. Nasser B, Tageldein M, Mesned AL, Kabbani M. Effects of blood transfusion on oxygen extraction ratio and central venous saturation in children after cardiac surgery. Ann Saudi Med. 2017;37(1):31–37. doi: 10.5144/0256-4947.2017.31
  20. Zhiburt EB. New clinical recommendations on transfusiology: Problems and solutions. Spravochnik zaveduyushchego KDL. 2022;(1):21–24. EDN: CXINBZ
  21. Zhiburt EB, Kuznetsov SI, Chemodanov IG, et al. New in transfusiology (at the virtual congress of the international society of blood transfusion). Transfuziologiya. 2021;22(1):47–64. EDN: YVWZAZ
  22. National Blood Authority (NBA). Patient blood management guidelines module 6: Neonatal and paediatrics. Canberra, Australia: NBA; 2016.
  23. Zhiburt EB. Children's transfusiology: A guide for doctors. Moscow: GEOTAR-Media; 2023. 163 р. (In Russ.)
  24. Grigoryants RG, Samsonova NN, Osilov KK, et al. First experience of using virally inactivated donor plasma during cardiac and vascular surgery in newborns and children of the first year of life. Clin Physiol Circulat. 2012;(3):53–56. EDN: RWOXHB
  25. Eihler OV, Chechetkin AV, Ajigitova EV, et al. Characteristics of transfusion reactions and complications in medical organizations of the russian federation in 2019. Transfuziologiya. 2022;(21):304–312. EDN: PFCQUQ
  26. Guo K, Ma S. The Immune system in transfusion-related acute lung injury prevention and therapy: Update and perspective. Front Mol Biosci. 2021;(8):639976. doi: 10.3389/fmolb.2021.639976
  27. Yu Y, Lian Z. Update on transfusion-related acute lung injury: An overview of its pathogenesis and management. Front Immunol. 2023;(14):1175387. doi: 10.3389/fimmu.2023.1175387
  28. Moore CM, D'Amore A, Fustolo-Gunnink S, et al. Two-year outcomes following a randomised platelet transfusion trial in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2023;108(5):452–457. doi: 10.1136/archdischild-2022-324915
  29. Ree IM, Lopriore E. Updates in neonatal hematology: Causes, risk factors, and management of anemia and thrombocytopenia. Hematol Oncol Clin North Am. 2019;33(3):521–532. doi: 10.1016/j.hoc.2019.01.013
  30. Patel RM, Josephson C. Neonatal and pediatric platelet transfusions: Current concepts and controversies. Curr Opin Hematol. 2019;26(6):466–472. doi: 10.1097/MOH.0000000000000542
  31. Norton T, Newberry D, Jnah A. Neonatal alloimmune thrombocytopenia: A concise review. Adv Neonatal Care. 2021;21(2):115–121. doi: 10.1097/ANC.0000000000000775
  32. Resolution of the Chief State Sanitary Doctor of the Russian Federation of 28 January 2021, No. 4 "On Approval of Sanitary Rules and Norms SanPiN 3.3686-21 "Sanitary and Epidemiological Requirements for the Prevention of Infectious Diseases" (as amended and supplemented), p. 652. (In Russ). Available from: https://base.garant.ru/400342149/?ysclid=lumg8jg72p61679652. Accessed: 15.01.2024.
  33. Chemodanov IG, Averyanov EG, Kuznetsov SI, et al. Hemovigilance in the UK. Transfuziologiya. 2020;21(1):68–78. EDN: VWXXHM
  34. Mowla SJ, Kracalik IT, Sapiano MR, et al. A comprasion of transfusion-related adverse reactions among apheresis platelets, whole blood-derived platelets, and platelets subjected to pathogen reduction technology as reported to the National Healthcare Safety Network Hemovigilance Module. Transfus Med. Rev. 2021;35(2):78–84. doi: 10.1016/j.tmrv.2021.03.003
  35. Vossoughi S, Gorlin J, Kessler DA, et al. Ten years of TRALI mitigation: Measuring our progress. Transfusion. 2019;59(8):2567–2574. doi: 10.1111/trf.15387
  36. Kuldanek SA, Kelher M, Silliman CC. Risk factors, management and prevention of transfusion-related acute lung injury: A comprehensive update. Expert Rev Hematol. 2019;12(9):773–785. doi: 10.1080/17474086.2019.1640599
  37. Khamitov RG, Gavriley AV, Drozhzhina IE, et al. Difficulties in the pooled platelets implementation. Tromboz, gemostaz i reologia. 2022;(4):22–29. EDN: YHBZVI doi: 10.25555/THR.2022.4.1037
  38. Grocott HP, Jones PM. Fibrinogen concentrate compared to cryoprecipitate to reduce transfusion in infants undergoing cardiac surgery: How confident can we be? Anesth Analg. 2020;131(2):e83–e84. doi: 10.1213/ANE.0000000000004885
  39. Downey LA, Andrews J, Hedlin H, et al. Fibrinogen concentrate as an alternative to cryoprecipitate in a postcardiopulmonary transfusion algorithm in infants undergoing cardiac surgery: A prospective randomized controlled trial. Anesth Analg. 2020;130(3):740–751. EDN: HGSSQB doi: 10.1213/ANE.0000000000004384
  40. Surti J, Jain I, Mishra A, et al. Venoarterial extra corporeal membrane oxygenation and blood component usage in pediatric patients undergoing cardiac surgery: Single centre experience. Ann Card Anaesth. 2021;24(2):203–208. doi: 10.4103/aca.ACA_112_19
  41. Crighton GL, Huisman EJ. Pediatric fibrinogen PART II-overview of indications for fibrinogen use in critically ILL children. Front Pediatr. 2021;(9):647680. EDN: SBGSPM doi: 10.3389/fped.2021.647680

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Zyuzin V.S.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies